Loading...
BB Biotech AG
BION.SW•SIX
HealthcareBiotechnology
CHF30.85
CHF0.15(0.49%)
BB Biotech AG (BION.SW) Company Profile & Overview
Explore BB Biotech AG’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
BB Biotech AG (BION.SW) Company Profile & Overview
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
SectorHealthcare
IndustryBiotechnology
CEODr. Daniel Koller Ph.D.
Contact Information
Company Facts
10 Employees
IPO DateJan 4, 2000
CountryCH
Actively Trading